Research also showed that L-norvaline inhibited the activity of ribosomal protein S6 kinase β-1 (S6K1) and that it possessed anti-inflammatory properties [33], indicating that L-norvaline could be extremely effective in AD. Here, RPS6KB1 is linked to Alzheimer disease.